lobbying_activities: 1267068

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1267068	7afd5a90-2378-486b-b1c9-9687ed1de9a8	Q2	VENABLE LLP	39941	ENDO PHARMACEUTICALS INC	2012	second_quarter	PHA	General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act; H.R. 5651.) The Life Sciences Investment Act (S. 1410; H.R. 2632)	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2012-07-17T16:14:17.010000-04:00